Groundbreaking drug delivery platform that precisely delivers various drugs to targeted lesions by loading them into cell-derived vesicles (CDVs) derived from human cells.
Business Model
BioDrone™ Platform Technology
BioDrone™ Platform Technology
MDimune is currently seeking partners for R&D collaborations that utilize the BioDrone™ (CDVs) platform for next-generation cell therapies or targeted payload delivery.
Open Innovation
BioDrone™ Platform Technology
Open Innovation
Flexible business model to collaborate with pharma/biotech partners in diverse therapeutic areas (cancer, rare diseases, CNS disorders, etc.).